drugset
drugset / Trial / NCT04754243

New Protocol in Unexplained Infertility

NCT04754243 ↗

Phase 4 Unknown 200 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

The new protocol ANTIUI provides good results regarding ovulation and pregnancy rates in patients with unexplained infertility

Timeline

Start
2021-03-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetrorelix Other / unclassified — —

Indications

infertility disorder